Home » Topics » BioWorld Science

BioWorld Science
RSS

ICN will market fluoxetine in Russia, ex-Yugoslavia

May 24, 1996

Fujisawa, Nihon Shokubai claim CCK-B antagonists

May 24, 1996

ADIR claims melatonin receptor ligands for CNS disorders

May 24, 1996

Eagle Research to license Oral-Assist products

May 24, 1996

Orphan drug status for CEA-Scan

May 24, 1996

Peptide Therapeutics, Dr. Fooke to research arthritis diagnostics

May 24, 1996

Isis claims oligonucleotides for diagnostic use

May 24, 1996

Atrix completes phase III studies of Atridox

May 24, 1996

PolyHeme phase II results in trauma patients announced

May 24, 1996

RF-1051 receives orphan drug status in PWS

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...